Quote request Get in touch

Introduction

airinspace’s HEPA MD® airborne elimination technology has become the benchmark in bone marrow transplant units. It has been internationally validated by numerous independent laboratories. It has been selected by most university hospitals in France, in particular to prevent infections in immunocompromised patients in haematology, bone marrow and solid organ transplant units or ICU.

Originally developed for air treatment in MIR and ISS space stations, the HEPA-MD® elimination technology was patented by airinspace and applied to the specific requirements of the hospital environment:

  • The only technology offering demonstrated protection of immunocompromised patients from the risk of invasive aspergillosis (Gerlinger study, 2016)
  • Destruction of microorganisms (bacteria, viruses, yeasts, fungi and spores)
  • Limited proliferation of filamentous fungi
  • Retention of particles and Volatile Organic Compounds (VOC)
  • Reduction in the ozone level

At the heart of the HEPA-MD® airborne disinfection technology

The HEPA-MD® reactor developed by airinspace combines the effectiveness of 4 air handling technologies on a number of levels:

01
Cold plasma microbiological destruction
Irreversible destruction of microorganisms by exposure to high electric fields and oxidising species in cold plasma chambers.
Cold plasma microbiological destruction
02
Biological decontamination and particle removal via HEPA 14 filtration
Microbiological and particulate retention thanks to the very high efficiency HEPA 14 filter, integrated into the second module of the HEPA-MD® reactor.
Biological decontamination and particle removal via HEPA 14 filtration
03
Catalytic molecular treatment
Removal of volatile molecular compounds in the catalytic converter. Transformation of particles containing inert molecules.
Catalytic molecular treatment
04
Treatment of odours and gases by adsorption
Adsorption of the aromatic compounds responsible for unpleasant odours on activated carbon.
Treatment of odours and gases by adsorption

6 good reasons to protect your patients with HEPA-MD® Technology

  • Broad-spectrum effectiveness: destruction of microorganisms, including filamentous fungi, and retention of chemical compounds and particles
  • No build-up of microorganisms in the HEPA filter
  • H14/U15 HEPA filters inspected one by one at the end of the manufacturing process in accordance with standard EN 1822 and tracking by serial number
  • No release of toxic compounds
  • Removal of unpleasant odours
  • Low energy consumption

Studies and publications

Mobile air filtration devices to help care for haematology patients with aplasia. Martin I, Forges F, Tavernier E, Cornillon J, Raberin H, Guyotat D Berthelot P, XXIX congrès
PLASMAIR® mobile air decontamination units reduce the incidence of Invasive Aspergillosis in neutropenic patients in haematology
Reduction in the incidence of Invasive Aspergillosis in neutropenic patients in haematology with PLASMAIR®
Mobile air handling unit: We tested their efficiency!!
Mobile air filtration devices to help care for haematology patients with aplasia
Creation of a controlled environment in clean rooms by means of a mobile air decontamination unit for the preparation of antineoplastic drugs
Evaluation of a mobile decontamination device for air control in the operating room
Reduction in the fungal contamination of the indoor environment with the PLASMAIR® system

HPVPA process
Learn more
Chemical adsorption
Learn more
HEPA filtration
Learn more